Last edition
News about "autoimmune disorders"
US FDA Approves Dr Reddy's Rituximab Biosimilar for the US Market
Dr Reddy's Laboratories has secured US FDA approval for its rituximab biosimilar, expanding its global biosimilars portfolio and strengthening its presence in the US biologics market.
Autoimmune Disorders | 03/08/2026 | By News Bureau
US-based biotechnology company Kaigene has signed an exclusive global licensing agreement with South Korean biopharmaceutical giant Celltrion to develop and commercialise two of its nonclinical-stage antibody assets, KG006 and KG002.
Autoimmune Disorders | 04/11/2025 | By Dineshwori | 876
Lupin Introduces Rymti Biosimilar Etanercept in Canada
Lupin Ltd. has developed Rymti, Lupin’s first biosimilar in Canada, through its partner Sandoz Canada (Sandoz).
Autoimmune Disorders | 06/05/2024 | By Aishwarya | 617
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy